Tenet Healthcare Corporation
269.08USD
+10.0200 (+3.87%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 19.2B | 20.6B | 20.7B | 21.3B | 22.4B | 22.5B |
| Q1 | 4.7B | 5.0B | 5.4B | 5.2B | 5.4B | — |
| Q2 | 4.6B | 5.1B | 5.1B | 5.3B | 5.6B | — |
| Q3 | 4.8B | 5.1B | 5.1B | 5.3B | 5.5B | — |
| Q4 | 5.0B* | 5.4B* | 5.1B* | 5.5B* | 5.8B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.79 | 5.71 | 32.70 | 15.49 | 21.22 | 21.08 |
| Q1 | 1.28 | 1.32 | 21.38 | 4.27 | 8.01 | — |
| Q2 | .350 | 1.15 | 2.64 | 3.14 | 9.84 | — |
| Q3 | 1.16 | .940 | 4.89 | 3.86 | 4.67 | — |
| Q4 | 2.48* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 4.35* |
| 5.84* |
| 7.09* |
| 5.68 |
| — |